Gaming and Training Combined to Help Adolescents Get More Physically Active

Increasing Physical Activity Among Adolescents With Motivational High-Intensity Training Through a Cutting-Edge Gaming Platform

The purpose of this study is to investigate if playing a newly developed videogame that requires physical activity (e.g. exergame), leads to increased physical activity and health benefits in children and adolescents who do not regularly participate in endurance training. Health benefits will be expressed in physical fitness (maximal oxygen consumption), blood markers of a healthy heart, body composition and objectively measured physical activity. Gaming frequency of the participants will be registered throughout the 24 week intervention period.

Study Overview

• Status: Terminated
• Conditions: Sedentary Lifestyle
• Intervention / Treatment: Behavioral: Exergaming

• Study Type: Interventional
• Enrollment (Actual): 29
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Norway
  • Trondheim, Norway, 7491
    • Department of Circulation and Medical Imaging

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 12 years to 18 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Not regularly participating in endurance training
• Sedentary (<60 mins daily moderate/vigorous intensity physical activity)
• Play video games > 10 hours/week (self-reported)
• Able to ride a bike for up to 60 minutes

Exclusion Criteria:

• Known cardiovascular disease
• Type I diabetes

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Exergaming; 24 week access to the exergaming platform PlayPulse	Behavioral: Exergaming; free access to the exergaming platform PlayPulse for 24 weeks; Other Names: PlayPulse
No Intervention: Control; Asked to continue with their normal daily routine

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
VO2max	Maximal Aerobic Capacity	12 weeks
VO2max	Maximal Aerobic Capacity	24 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in daily average energy expenditure	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.	Baseline, 12 and 24 weeks
Change in daily time in sedentary activity (<3.0 metabolic equivalents =METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.	Baseline, 12 and 24 weeks
Change in daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.	Baseline, 12 and 24 weeks
Change in daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.	Baseline, 12 and 24 weeks
Change in daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.	Baseline, 12 and 24 weeks
Change in daily average total physical activity duration	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.	Baseline, 12 and 24 weeks
Change in daily average number of steps	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.	Baseline, 12 and 24 weeks
Bioelectrical impedance	Body composition assessed using bioelectrical impedance analysis (InBody 720)	12 and 24 weeks
systolic Blood Pressure		12 and 24 weeks
Diastolic Blood Pressure		12 and 24 weeks
Fasting circulating glucose, as blood marker of cardiometabolic health		24 weeks
Lipid profile, as blood marker of cardiometabolic health		24 weeks
Circulating insulin concentration, as blood marker of cardiometabolic health		24 weeks
HbA1c from blood samples		24 weeks

Collaborators and Investigators

• Sponsor: Norwegian University of Science and Technology

Study record dates

Study Major Dates

• Study Start (Actual): February 11, 2019
• Primary Completion (Actual): April 7, 2021
• Study Completion (Actual): April 7, 2021

Study Registration Dates

• First Submitted: September 6, 2018
• First Submitted That Met QC Criteria: September 6, 2018
• First Posted (Actual): September 10, 2018

Study Record Updates

• Last Update Posted (Actual): April 23, 2021
• Last Update Submitted That Met QC Criteria: April 21, 2021
• Last Verified: April 1, 2021

More Information

Terms related to this study

• Keywords: Adolescents; Children; Physical Fitness; Exercise Therapy; Exercise Test; Healthy Lifestyle; Games, Recreational
• Other Study ID Numbers: 2018/633

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No